|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02898 SUNHO BIO-B
Nominal 
5.110 +0.110 (+2.200%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (40,653) | (34,586) |
| Net Cash from / (used in) Investing Activities | -- | (83,888) | (1,362) |
| Net Cash from / (used in) Financing Activities | -- | 255,497 | 27,104 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 130,956 | (8,844) |
| Cash & Cash Equivalents at beginning of period | -- | 1,821 | 10,665 |
| Effect of Foreign Exchange Rate Changes | -- | (7,703) | 0 |
| Others | -- | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 125,074 | 1,821 |
| Remarks: | Real time quote last updated: 05/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -36,077,000 |
| %Change | -41.328% |
| EPS / (LPS) | RMB -0.340 |
| NBV Per Share (¥) | RMB 3.498 |